BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25743476)

  • 1. Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.
    Huang T; Perez-Cordon G; Shi L; Li G; Sun X; Wang X; Wang J; Feng H
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25743476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prosurvival Pathway Protects From Clostridioides difficile Toxin-Mediated Cell Death.
    Tornel W; Sharma I; Osmani H; Moonah S
    J Infect Dis; 2024 May; 229(5):1519-1522. PubMed ID: 37972231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.
    Richardson C; Kim P; Lee C; Bersenas A; Weese JS
    Anaerobe; 2015 Jun; 33():105-8. PubMed ID: 25769665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses.
    Rojo D; Gosalbes MJ; Ferrari R; Pérez-Cobas AE; Hernández E; Oltra R; Buesa J; Latorre A; Barbas C; Ferrer M; Moya A
    ISME J; 2015 Oct; 9(10):2206-20. PubMed ID: 25756679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of adhesion of Clostridium difficile to human intestinal cells after treatment with serum and intestinal fluid isolated from mice immunized with nontoxigenic C. difficile membrane fraction.
    Senoh M; Iwaki M; Yamamoto A; Kato H; Fukuda T; Shibayama K
    Microb Pathog; 2015 Apr; 81():1-5. PubMed ID: 25745878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.
    Eckert C; Emirian A; Le Monnier A; Cathala L; De Montclos H; Goret J; Berger P; Petit A; De Chevigny A; Jean-Pierre H; Nebbad B; Camiade S; Meckenstock R; Lalande V; Marchandin H; Barbut F
    New Microbes New Infect; 2015 Jan; 3():12-7. PubMed ID: 25755885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of toxemia in patients with Clostridium difficile infection.
    Yu H; Chen K; Wu J; Yang Z; Shi L; Barlow LL; Aronoff DM; Garey KW; Savidge TC; von Rosenvinge EC; Kelly CP; Feng H
    PLoS One; 2015; 10(4):e0124235. PubMed ID: 25885671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).
    Hemmasi S; Czulkies BA; Schorch B; Veit A; Aktories K; Papatheodorou P
    J Biol Chem; 2015 May; 290(22):14031-44. PubMed ID: 25882847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a true bacteriotherapy for Clostridium difficile infection.
    Rupnik M
    N Engl J Med; 2015 Apr; 372(16):1566-8. PubMed ID: 25875262
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile infection.
    Leffler DA; Lamont JT
    N Engl J Med; 2015 Apr; 372(16):1539-48. PubMed ID: 25875259
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.
    Lewis BB; Buffie CG; Carter RA; Leiner I; Toussaint NC; Miller LC; Gobourne A; Ling L; Pamer EG
    J Infect Dis; 2015 Nov; 212(10):1656-65. PubMed ID: 25920320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium Difficile Infection in the United States: A National Study Assessing Preventive Practices Used and Perceptions of Practice Evidence.
    Saint S; Fowler KE; Krein SL; Ratz D; Flanders SA; Dubberke ER; Greene MT
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):969-71. PubMed ID: 25896321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.
    van Werkhoven CH; van der Tempel J; Jajou R; Thijsen SF; Diepersloot RJ; Bonten MJ; Postma DF; Oosterheert JJ
    Clin Microbiol Infect; 2015 Aug; 21(8):786.e1-8. PubMed ID: 25889357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.
    Hirsch BE; Saraiya N; Poeth K; Schwartz RM; Epstein ME; Honig G
    BMC Infect Dis; 2015 Apr; 15():191. PubMed ID: 25885020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised phase 1 study to investigate safety, pharmacokinetics and impact on gut microbiota following single and multiple oral doses in healthy male subjects of SMT19969, a novel agent for Clostridium difficile infections.
    Vickers R; Robinson N; Best E; Echols R; Tillotson G; Wilcox M
    BMC Infect Dis; 2015 Feb; 15():91. PubMed ID: 25880933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized Protocol for Simple Extraction of High-Quality Genomic DNA from Clostridium difficile for Whole-Genome Sequencing.
    Sim JH; Anikst V; Lohith A; Pourmand N; Banaei N
    J Clin Microbiol; 2015 Jul; 53(7):2329-31. PubMed ID: 25878343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients.
    Abdelfatah M; Nayfe R; Nijim A; Enriquez K; Ali E; Watkins RR; Kandil H
    J Investig Med; 2015 Jun; 63(5):747-51. PubMed ID: 25871748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line.
    Aguado JM; Anttila VJ; Galperine T; Goldenberg SD; Gwynn S; Jenkins D; Norén T; Petrosillo N; Seifert H; Stallmach A; Warren T; Wenisch C;
    J Hosp Infect; 2015 Jun; 90(2):117-25. PubMed ID: 25842241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial commentary: Clostridium difficile ribotype 027: an intrinsically virulent strain, but clinical virulence remains to be determined at the bedside.
    Goorhuis A
    Clin Infect Dis; 2015 Jul; 61(2):242-3. PubMed ID: 25828996
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.
    Rao K; Micic D; Natarajan M; Winters S; Kiel MJ; Walk ST; Santhosh K; Mogle JA; Galecki AT; LeBar W; Higgins PD; Young VB; Aronoff DM
    Clin Infect Dis; 2015 Jul; 61(2):233-41. PubMed ID: 25828993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.